国际检验医学杂志
國際檢驗醫學雜誌
국제검험의학잡지
International Journal of Laboratory Medicine
2015年
17期
2485-2486,2489
,共3页
贺家勇%王国良%张华彬%杨晨晨
賀傢勇%王國良%張華彬%楊晨晨
하가용%왕국량%장화빈%양신신
恶性肿瘤%凝血功能%临床特征
噁性腫瘤%凝血功能%臨床特徵
악성종류%응혈공능%림상특정
malignancy%coagulation%clinical features
目的:探讨不同类型的恶性肿瘤患者凝血功能与其肿瘤分期、淋巴结转移的关系。方法选取2010年1月至2014年12月于该院住院的恶性肿瘤患者135例,选取同期于本院体检且合格的健康者57例纳入对照组。检测恶性肿瘤患者及对照组人群凝血酶原时间(PT)、凝血酶凝固时间(TT)、活化部分凝血活酶时间(APTT)、D‐二聚体、纤维蛋白原(FIB)水平,并对不同肿瘤分期、不同淋巴结转移情况的同类型恶性肿瘤患者的凝血功能相关指标进行比较和分析。结果与对照组比较,恶性肿瘤患者PT、APTT缩短,D‐二聚体及FIB水平升高(P<0.05)。食管癌、乳腺癌、胃癌患者PT、TT、APTT 较肺癌组延长,D‐二聚体及FIB水平较肺癌组降低(P<0.05)。恶性肿瘤(肺癌、食管癌、乳腺癌、胃癌)患者Ⅲ~Ⅳ期PT、TT、APTT 缩短,而D‐二聚体、FIB水平升高(P<0.05)。有淋巴结转移的恶性肿瘤患者较无淋巴结转移者PT、TT、APTT缩短,FIB水平增高(P<0.05)。结论恶性肿瘤患者血液存在高凝状态。不同临床分期、淋巴结转移情况不同的恶性肿瘤患者凝血功能也有差异,凝血功能的异常有可能参与了肿瘤的进展和转移。
目的:探討不同類型的噁性腫瘤患者凝血功能與其腫瘤分期、淋巴結轉移的關繫。方法選取2010年1月至2014年12月于該院住院的噁性腫瘤患者135例,選取同期于本院體檢且閤格的健康者57例納入對照組。檢測噁性腫瘤患者及對照組人群凝血酶原時間(PT)、凝血酶凝固時間(TT)、活化部分凝血活酶時間(APTT)、D‐二聚體、纖維蛋白原(FIB)水平,併對不同腫瘤分期、不同淋巴結轉移情況的同類型噁性腫瘤患者的凝血功能相關指標進行比較和分析。結果與對照組比較,噁性腫瘤患者PT、APTT縮短,D‐二聚體及FIB水平升高(P<0.05)。食管癌、乳腺癌、胃癌患者PT、TT、APTT 較肺癌組延長,D‐二聚體及FIB水平較肺癌組降低(P<0.05)。噁性腫瘤(肺癌、食管癌、乳腺癌、胃癌)患者Ⅲ~Ⅳ期PT、TT、APTT 縮短,而D‐二聚體、FIB水平升高(P<0.05)。有淋巴結轉移的噁性腫瘤患者較無淋巴結轉移者PT、TT、APTT縮短,FIB水平增高(P<0.05)。結論噁性腫瘤患者血液存在高凝狀態。不同臨床分期、淋巴結轉移情況不同的噁性腫瘤患者凝血功能也有差異,凝血功能的異常有可能參與瞭腫瘤的進展和轉移。
목적:탐토불동류형적악성종류환자응혈공능여기종류분기、림파결전이적관계。방법선취2010년1월지2014년12월우해원주원적악성종류환자135례,선취동기우본원체검차합격적건강자57례납입대조조。검측악성종류환자급대조조인군응혈매원시간(PT)、응혈매응고시간(TT)、활화부분응혈활매시간(APTT)、D‐이취체、섬유단백원(FIB)수평,병대불동종류분기、불동림파결전이정황적동류형악성종류환자적응혈공능상관지표진행비교화분석。결과여대조조비교,악성종류환자PT、APTT축단,D‐이취체급FIB수평승고(P<0.05)。식관암、유선암、위암환자PT、TT、APTT 교폐암조연장,D‐이취체급FIB수평교폐암조강저(P<0.05)。악성종류(폐암、식관암、유선암、위암)환자Ⅲ~Ⅳ기PT、TT、APTT 축단,이D‐이취체、FIB수평승고(P<0.05)。유림파결전이적악성종류환자교무림파결전이자PT、TT、APTT축단,FIB수평증고(P<0.05)。결론악성종류환자혈액존재고응상태。불동림상분기、림파결전이정황불동적악성종류환자응혈공능야유차이,응혈공능적이상유가능삼여료종류적진전화전이。
Objective To investigate the relationship between the clinical features of patients with different cancer and their clin‐icalstage,lymphnodemetastasissituation.Methods 135cancerpatientsdiagnosedandtreatedinthehospitalfromJanuary2010to December 2014 were enrolled in the study ,in addition to that ,57 people who underwent healthy examination in the hospital and proved to be healthy were also recruited as control group .Prothrombin time(PT) ,thrombin clotting time(TT) ,activated partial thromboplastin time(APTT) ,D‐dimer ,fibrinogen(FIB) were tested for the people mentioned above .Results The level of routine coagulation indicators were statistically significant different between people with different types of cancers and control group(P<0 .05) .Compared with the control group ,PT ,APTT of the cancer patients significantly shortened ,FIB ,D‐dimer levels were signifi‐cantly increased(P<0 .05) .PT ,APTT was prolonged in lung cancer ,esophageal cancer ,breast cancer ,stomach cancer compared with lung cancer ,FIB ,D‐dimer decreased compared with other malignancies(P<0 .05) .PT ,APTT was decreased and D‐dimer ,FIB was significantly increased in cancer(lung ,esophagus ,breast ,stomach) with Ⅲ‐Ⅳ stage or lymph node metastasis than Ⅰ‐Ⅱstage or non‐lymph node metastasis ,the difference was statistically significant(P<0 .05) .Conclusion The malignant tumors were with hypercoagulable state ,there are differences in coagulation in different clinical stages ,lymph node metastasis .